Additional file 1: of Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated with Sorafenib

Figure S1. Scatter plot demonstrating the correlation of the I-score with the total cell-free DNA concentration. Figure S2. Kaplan-Meier curves for (A) time to progression and (B) overall survival according to the VEGFA ratio. Abbraviation: VEGFA, vascular endothelial growth factor-A. (DOCX172 Kb)